Abstract | AIMS: METHODS: A sub-cohort (n = 35; 48% men; 74% Caucasian) from the HART-D study undertaking muscle biopsies before and after 9 months of aerobic (AT), resistance (RT), or combination training (ATRT). RESULTS: Changes in HbA1C were associated with changes in adiponectin (r = -0.45, P = 0.007). Participants diagnosed with type 2 diabetes for a longer duration had the largest increase in PGC-1α (r = 0.44, P = 0.008). Statistical modeling examining changes in HbA1C suggested that male sex (P = 0.05), non-Caucasian ethnicity (P = 0.02), duration of type 2 diabetes (r = 0.40; P<0.002) and changes in FFA (r = 0.36; P<0.004), adiponectin (r = -0.26; P<0.03), and PGC-1α (r = -0.28; P = 0.02) explain ∼65% of the variability in the changes in HbA1C. CONCLUSIONS: Decreases in HbA1C after 9 months of exercise were associated with shorter duration of diabetes, lowering of serum FFA concentrations, increasing serum adiponectin concentrations and increasing skeletal muscle PGC-1α protein expression. TRIAL REGISTRATION: ClinicalTrials.gov NCT00458133.
|
Authors | Neil M Johannsen, Lauren M Sparks, Zhengyu Zhang, Conrad P Earnest, Steven R Smith, Timothy S Church, Eric Ravussin |
Journal | PloS one
(PLoS One)
Vol. 8
Issue 6
Pg. e62973
( 2013)
ISSN: 1932-6203 [Electronic] United States |
PMID | 23805175
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- ADIPOQ protein, human
- Adiponectin
- Glycated Hemoglobin A
- PPARGC1A protein, human
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
- hemoglobin A1c protein, human
|
Topics |
- Adiponectin
(blood)
- Adult
- Aged
- Diabetes Mellitus, Type 2
(blood, therapy)
- Exercise Therapy
- Female
- Glycated Hemoglobin
(metabolism)
- Glycemic Index
- Humans
- Male
- Middle Aged
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
(blood)
- Time Factors
|